GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,468,000 | +9.9% | 33,732 | +9.9% | 0.01% | +75.0% |
| Q1 2022 | $1,336,000 | +1.1% | 30,680 | +2.4% | 0.00% | +33.3% |
| Q4 2021 | $1,322,000 | +17.9% | 29,974 | +2.2% | 0.00% | 0.0% |
| Q3 2021 | $1,121,000 | -4.0% | 29,332 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,168,000 | +11.6% | 29,332 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,047,000 | -3.0% | 29,332 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,079,000 | -2.3% | 29,332 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,104,000 | -7.7% | 29,332 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $1,196,000 | -46.2% | 29,332 | -50.0% | 0.00% | -20.0% |
| Q1 2020 | $2,222,000 | +57.6% | 58,664 | +95.5% | 0.01% | 0.0% |
| Q4 2019 | $1,410,000 | +10.1% | 30,007 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $1,281,000 | +7.3% | 30,007 | +0.6% | 0.01% | 0.0% |
| Q2 2019 | $1,194,000 | -24.4% | 29,824 | -21.1% | 0.01% | -16.7% |
| Q1 2019 | $1,580,000 | +22.1% | 37,815 | +11.7% | 0.01% | 0.0% |
| Q4 2018 | $1,294,000 | -4.9% | 33,869 | 0.0% | 0.01% | +20.0% |
| Q3 2018 | $1,361,000 | -0.3% | 33,869 | 0.0% | 0.01% | -16.7% |
| Q2 2018 | $1,365,000 | +1.3% | 33,869 | -1.8% | 0.01% | 0.0% |
| Q1 2018 | $1,347,000 | +10.1% | 34,485 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $1,223,000 | -22.2% | 34,485 | -10.9% | 0.01% | -14.3% |
| Q3 2017 | $1,572,000 | -7.1% | 38,712 | -1.3% | 0.01% | -12.5% |
| Q2 2017 | $1,692,000 | +29.3% | 39,236 | +26.4% | 0.01% | +14.3% |
| Q1 2017 | $1,309,000 | -42.4% | 31,051 | -47.4% | 0.01% | -41.7% |
| Q4 2016 | $2,274,000 | -29.4% | 59,048 | -21.0% | 0.01% | -29.4% |
| Q3 2016 | $3,223,000 | +3.7% | 74,725 | +4.2% | 0.02% | +6.2% |
| Q2 2016 | $3,109,000 | +17.5% | 71,725 | +10.0% | 0.02% | +23.1% |
| Q1 2016 | $2,645,000 | +104.1% | 65,225 | +103.0% | 0.01% | +116.7% |
| Q4 2015 | $1,296,000 | +1.2% | 32,125 | -3.6% | 0.01% | -14.3% |
| Q3 2015 | $1,281,000 | -7.7% | 33,325 | 0.0% | 0.01% | +16.7% |
| Q2 2015 | $1,388,000 | +35.0% | 33,325 | +49.7% | 0.01% | +20.0% |
| Q1 2015 | $1,028,000 | – | 22,267 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |